Abstract:Objective To evaluate the effectiveness of terazosin, tamsulosin and fin asteride for benign prostatic hyperplasia (BPH). Methods We searched the related original studies all over the world , and only included randomized controlled trials (RCT) and quasi-randomized con trolled trials (CCT). MEDLINE (1966Dec. 2004), EMBASE (1984Dec . 2004), The Cochrane Library (Issue 4, 2004) and four Chinese databases were electronically searched and 10 related journals were handsearched . The studies included in the references of eligible studies were additionally searched. Two reviewers independently screened the studies for eligibility, eva luated the quality and extracted the data from the eligible studies, with confir mation by cross-checking. Divergences of opinion were consulted by a third part y. Meta-analysis was performed by using RevMan 4.2 software. Results Twelve original studies involving 2 471 participants met inclusion criteria. Compared with terazosin, tamsulosin could improve inter national prostatic symptom score, with WMD 0.75, 95% confidence interval (CI) 0.03 to 1 .46, P=0.04. There was no statistical difference between teraz osin and tamsulosin in improving the average rate of urine flow (WMD 0.23, 95%C I -0.39 to 0.85, P= 0.46), the residual urine volume (WMD 0.82, 95%CI -2.92 to 4.57, P =0.67) and in diminishing the volume of prostate (WMD=2.20, 95%CI -3 .99 to 8.39, P=0.49). There was no statistical difference bet ween finasteride and tamsulosin in improving the international prostatic symptom score (WMD 0.65, 95%CI -0.45 to 1.75, P=0.25) or the max r ate of urine flow (WMD 0.39, 95%CI -0.72 to 1.51, P=0.49). Only two studies compared finasteride with terazosin and had different conclusio ns. Only one study compared finasteride or terazosin with a combination of these drugs suggested that the combination had higher effective power than finasterid e alone but no difference with terazosin alone. Conclusions Although the effectiveness in some aspects is higher in the tamsul osin group, there is not enough evidence to show which one is the best among the se three drugs. The combination of finasteride and terazosin does not show more effectiveness than terazosin alone. This review suggests that tamsulosin alone s hould be used for the treatment of BPH and the combination needs to be identifie d by better evidence. It is important to improve the quality of original studies .

Observation on Curative Efficacy of Tamsulosin Hydrochloride Sustained-Release Capsules Combined with Finasteride Tablets in the Treatment of Benign Prostatic Hyperplasia

Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

Clinical study of prostatic artery embolization combined with tamsulosin capsules in the treatment of benign prostatic hyperplasia

Efficacy and Safety of Long-Term Administration of Tamsulosin Hydrochloride in Patients with LUTS Suggestive of BPH

Effect of QianlieShutong capsule combined with tamsulosin on serum testosterone and estrogen in patients with benign prostatic hyperplasia and its efficacy

Evaluation on Safety and Efficacy of Finasteride in Treatment of Benign Prostatic Hyperplasia

Clinical Study of Combination Therapy of Tamsulosin and Solifenacin for Benign Prostatic Hyperplasia with Overactive Bladder

The efficacy of combination therapy of tamsulosin and Qianlie Beixi capsule in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

Treatment Efficacy and Safety Analysis of Tamsulosin Application for Advanced Prostate cancer

Impact of tamsulosin for benign prostatic hyperplasia on sexual function

Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia

The comparison between finasteride and tamsulosin therapeutic efficacy in the treatment of symptomatic benign prostate hyperplasia

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia

Clinical Effect of Tamsulosin and Proscar Combination in Treatment of Benign Prostatic Hyperplasia Patients with Different Ages

Evaluation of the Effectiveness of Terazosin, Tamsulosin a nd Finasteride for Benign Prostatic Hyperplasia

Clinical effect of Xipayimaibizi capsules combined with tamsulosin hydrochloride sustained-release tablets on type ⅢA chronic nonbacterial prostatitis

Application effects of solifenacin combined with tamsulosin in the mild and moderate benign prostatic hyperplasia with overactive bladder

Combination Therapy with Curcumin Plus Tamsulosin and Finasteride in the Treatment of Men with Benign Prostatic Hyperplasia: a Single Center, Randomized Control Study

Comparative study of tamsulosin versus tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms. A prospective randomized study

Clinical Observation of Tonglin Decoction Combined with Tamsulosin on Urodynamics and PSA Levels in Advanced Prostate Cancer Patients with Acute Urinary Retention

Combination of Tamsulosin and Tolterodine Alleviates Refractory Lower Urinary Tract Symptoms in Male Patients